Lyssavirus infection excluding rabies

Lyssaviruses constitute a genus of pathogens phylogenetically associated with the rabies virus, encompassing both established agents and recently characterized strains that continue to gain recognition in modern virology ^[2]. These viral groups are frequently classified within emerging infectious disease categories due to ongoing identification and periodic resurgence patterns ^[3]. Mammalian bat populations serve as primary biological reservoirs that facilitate the maintenance and ecological spread of these pathogens across diverse habitats ^[2].

Detailed clinical manifestations in human hosts remain poorly characterized due to limited data on viral pathogenesis within reservoir species ^[2]. Available observations indicate that natural infection routes in bat populations generally result in low mortality rates, with surviving individuals frequently demonstrating seroconversion ^[2]. Human clinical presentations are inferred through classical diagnostic frameworks traditionally applied to rabies management ^[2].

Bat species maintain widespread enzootic circulation of lyssaviruses, with distinct ecological drivers shaping regional incidence profiles ^[2]. Geographic distribution varies significantly, notably with haematophagous vampire bats functioning as dominant wildlife reservoirs throughout Latin American ecosystems ^[2]. In Australasia, fruit bat populations are associated with the localized emergence of Australian bat lyssavirus, reflecting ongoing characterization efforts within the region ^[2]. These pathogens reflect broader trends of newly identified viruses entering surveillance systems alongside the periodic resurgence of established endemic strains ^[3].

Bats frequently act as vectors of lyssaviruses. Transmission from an infected bat may occur through a bite, although other routes are also considered possible.^[2]

Evidence-backed detail for this section is not available yet.

Disease mitigation strategies predominantly utilize established control protocols originally developed for classical rabies management ^[2]. Certain endemic regions have additionally implemented specialized intervention techniques tailored to disrupt vampire bat population dynamics and reduce zoonotic spillover risk ^[2]. Laboratory confirmation pathways for suspected exposures similarly adhere to conventional diagnostic standards historically applied to rabies cases ^[2].

The global burden of human rabies is incompletely characterized because of inadequate surveillance. The recognition of enzootic European bat lyssavirus infection in the United Kingdom and the identification of Australian bat lyssavirus during a national surveillance program illustrate the role of surveillance in detecting lyssavirus circulation.^[4][5]

1. 1Banyard AC et al. Bats and lyssaviruses. Adv Virus Res. 2011. PMID: 21601050. doi: 10.1016/B978-0-12-387040-7.00012-3.PubMed: https://pubmed.ncbi.nlm.nih.gov/21601050/
2. 2McColl KA et al. Bat lyssavirus infections. Rev Sci Tech. 2000 Apr. PMID: 11189715. doi: 10.20506/rst.19.1.1221.PubMed: https://pubmed.ncbi.nlm.nih.gov/11189715/
3. 3Holland DJ et al. Emerging viruses. Curr Opin Pediatr. 1998 Feb. PMID: 9529635. doi: 10.1097/00008480-199802000-00007.PubMed: https://pubmed.ncbi.nlm.nih.gov/9529635/
4. 4Warrell MJ et al. Rabies and other lyssavirus diseases. Lancet. 2004 Mar 20. PMID: 15043965. doi: 10.1016/S0140-6736(04)15792-9.PubMed: https://pubmed.ncbi.nlm.nih.gov/15043965/
5. 5Wikipedia contributors. Australian bat lyssavirus [Internet]. Wikipedia. cited 11 Aug 2026.Available from: https://en.wikipedia.org/wiki/Australian_bat_lyssavirus